The Valley Desk

NCT01940172 · Interventional trial

Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer

Overall registry status Completed

Phase 1

Conditions Relapsed Epithelial Ovarian Cancer, Relapsed Fallopian Tube Cancer, Relapsed Primary Peritoneal Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov